Mathematics
Cancer
100%
Rare Events
62%
Importance Sampling
59%
Tumor
56%
Drug Resistance
54%
Mutant
42%
Timing
41%
Mutation
40%
Cell
38%
Therapy
37%
Resistance
36%
Recurrence
35%
Large Deviations
27%
Queue
27%
Spatial Model
27%
Schedule
24%
Recurrence Equations
24%
Leukemia
24%
Drugs
23%
Fitness
22%
Subsolution
22%
Rare Event Simulation
22%
Clone
22%
Radiation
21%
Carcinogenesis
20%
Stochastic Equations
19%
Model
17%
Phenotype
17%
Simulation
15%
Colorectal Cancer
14%
Asymptotically Optimal
14%
Reflecting Brownian Motion
13%
Policy
13%
Cell Proliferation
13%
Irradiation
13%
Lyapunov Inequality
13%
Efficient Estimation
12%
Wishart Matrix
12%
Sums of Random Variables
12%
Radiotherapy
12%
Driver
12%
Stochastic Modeling
12%
Multi-class
11%
Rate Function
11%
Single Server
11%
Progression
11%
Tumor Growth
11%
Medicine & Life Sciences
Neoplasms
57%
Appointments and Schedules
43%
Drug Resistance
36%
Glioblastoma
27%
Radiotherapy
26%
Radiation
26%
Recurrence
22%
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
21%
Protein-Tyrosine Kinases
20%
Epigenomics
19%
Uncertainty
18%
Phenotype
16%
Pharmaceutical Preparations
15%
Therapeutics
15%
Theoretical Models
15%
4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide
14%
Mutation
14%
Carcinogenesis
13%
O-(6)-methylguanine
12%
Growth
12%
Temozolomide
11%
Non-Small Cell Lung Carcinoma
11%
Preclinical Drug Evaluations
11%
Genetic Heterogeneity
10%
Population
10%
Methyltransferases
10%
Neoplastic Stem Cells
9%
Head and Neck Neoplasms
9%
Precursor Cell Lymphoblastic Leukemia-Lymphoma
9%
Tobacco
8%
Radiosurgery
8%
Cell Division
8%
Methylation
8%
Imatinib Mesylate
7%
Colorectal Neoplasms
7%
Population Dynamics
7%
Phosphotransferases
7%
Clone Cells
6%
Cell Proliferation
6%
Mutation Accumulation
6%
Kinetics
6%
Tumor Burden
6%
Brain Neoplasms
6%
Treatment Failure
6%
Drug Therapy
5%
Organs at Risk
5%
Mutation Rate
5%
Cell Death
5%
Survival
5%
DNA
5%
Agriculture & Biology
neoplasms
81%
drug resistance
36%
therapeutics
35%
myeloid leukemia
26%
mutation
24%
epigenetics
21%
carcinogenesis
17%
phenotype
15%
neoplasm progression
15%
cells
14%
statistical inference
14%
glioblastoma
13%
neoplasm cells
13%
lymphocytic leukemia
12%
radiotherapy
12%
drugs
11%
phosphotransferases (kinases)
11%
colorectal neoplasms
11%
tissues
10%
mathematical models
9%
stem cells
9%
mutation accumulation
9%
mutation rate
8%
cell proliferation
8%
plasticity
8%
drug therapy
8%
dosage
7%
tyrosine
7%
kinetics
7%
resistance mechanisms
6%
clones
5%
cell death
5%
branching
5%